We serve Chemical Name:3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine CAS:944902-17-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine](https://a.dearchem.com/CAS2/944902-17-4.png)
Chemical Name:3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine
CAS.NO:944902-17-4
Synonyms:3-bromo-4,6-dichloro-2H-pyrazolo[3,4-d]pyrimidine;1H-Pyrazolo[3,4-d]pyrimidine, 3-bromo-4,6-dichloro-;3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine
Molecular Formula:C5HBrCl2N4
Molecular Weight:267.898
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:2.2±0.1 g/cm3
Index of Refraction:1.765
PSA:54.46000
Exact Mass:265.876160
LogP:2.40
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-bromo-4,6-dichloro-2H-pyrazolo[3,4-d]pyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine Use and application,1H-Pyrazolo[3,4-d]pyrimidine, 3-bromo-4,6-dichloro- technical grade,usp/ep/jp grade.
Related News: TULIP-2 assessed the effect of anifrolumab in reducing disease activity as measured by the BILAG-Based Composite Lupus Assessment (BICLA) scale. In TULIP-1, 457 eligible patients were randomised (1:2:2) and received a fixed-dose intravenous infusion of 150mg anifrolumab, 300mg anifrolumab or placebo every four weeks, disodium 4,4′-[methylenebis(4,1-phenyleneimino)]bis[1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate] manufacturers Over the past few years, China has been offering AstraZeneca bragging rights. But the company’s business in the country is coming to a turning point after being exposed to the government’s price-cutting scheme and local competition—and investors have caught wind. azocarmine G suppliers The CDC’s delay likely came as a disappointment to representatives for the immunocompromised community, who pleaded with the CDC’s expert group to give the go-ahead for booster use in these people, who do not mount a strong enough defense against the virus. n-Butyl butanoate vendor & factory.
